Hallmarks of Aging in Age-related Macular Degeneration and Age-related Neurological Disorders: Novel Insights into Common Mechanisms and Clinical Relevance

Overview

Journal Eye (Lond)

Specialty Ophthalmology

Date 2024 Sep 17

PMID 39289517

Authors

Stela Vujosevic

Celeste Limoli

Igor Kozak

Affiliations

Soon will be listed here.

Abstract

Age-related macular degeneration (AMD) and age-related neurological diseases (ANDs), such as Alzheimer's and Parkinson's Diseases, are increasingly prevalent conditions that significantly contribute to global morbidity, disability, and mortality. The retina, as an accessible part of the central nervous system (CNS), provides a unique window to study brain aging and neurodegeneration. By examining the associations between AMD and ANDs, this review aims to highlight novel insights into fundamental mechanisms of aging and their role in neurodegenerative disease progression. This review integrates knowledge from the emerging field of aging research, which identifies common denominators of biological aging, specifically loss of proteostasis, impaired macroautophagy, mitochondrial dysfunction, and inflammation. Finally, we emphasize the clinical relevance of these pathways and the potential for cross-disease therapies that target common aging hallmarks. Identifying these shared pathways could open avenues to develop therapeutic strategies targeting mechanisms common to multiple degenerative diseases, potentially attenuating disease progression and promoting the healthspan.

References

Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch S, Croteau D . Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15(10):565-581. DOI: 10.1038/s41582-019-0244-7. View

Crane P, Wilkinson G, Teare H . Healthspan versus lifespan: new medicines to close the gap. Nat Aging. 2023; 2(11):984-988. DOI: 10.1038/s43587-022-00318-5. View

Bloem B, Okun M, Klein C . Parkinson's disease. Lancet. 2021; 397(10291):2284-2303. DOI: 10.1016/S0140-6736(21)00218-X. View

Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U . Age-Related Macular Degeneration: A Review. JAMA. 2024; 331(2):147-157. DOI: 10.1001/jama.2023.26074. View

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . Hallmarks of aging: An expanding universe. Cell. 2023; 186(2):243-278. DOI: 10.1016/j.cell.2022.11.001. View

Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A . Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018; 14(10):576-590. DOI: 10.1038/s41574-018-0059-4. View

Tysnes O, Storstein A . Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017; 124(8):901-905. DOI: 10.1007/s00702-017-1686-y. View

Vann Jones S, OBrien J . The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2013; 44(4):673-83. DOI: 10.1017/S0033291713000494. View

Azarpazhooh M, Avan A, Cipriano L, Munoz D, Sposato L, Hachinski V . Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement. 2017; 14(2):148-156. DOI: 10.1016/j.jalz.2017.07.755. View

10.

Kashani A, Asanad S, Chan J, Singer M, Zhang J, Sharifi M . Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021; 83:100938. PMC: 8280255. DOI: 10.1016/j.preteyeres.2020.100938. View

11.

Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A . Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses. JAMA Ophthalmol. 2022; 141(1):84-91. DOI: 10.1001/jamaophthalmol.2022.4845. View

12.

Pead E, Thompson A, Grewal D, McGrory S, Robbins C, Ma J . Retinal Vascular Changes in Alzheimer's Dementia and Mild Cognitive Impairment: A Pilot Study Using Ultra-Widefield Imaging. Transl Vis Sci Technol. 2023; 12(1):13. PMC: 9838583. DOI: 10.1167/tvst.12.1.13. View

13.

Zhou Y, Chia M, Wagner S, Ayhan M, Williamson D, Struyven R . A foundation model for generalizable disease detection from retinal images. Nature. 2023; 622(7981):156-163. PMC: 10550819. DOI: 10.1038/s41586-023-06555-x. View

14.

Xu Y, Phu J, Aung H, Hesam-Shariati N, Keay L, Tully P . Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis. Eye (Lond). 2023; 37(15):3128-3136. PMC: 10564749. DOI: 10.1038/s41433-023-02481-4. View

15.

Kuzma E, Littlejohns T, Khawaja A, Llewellyn D, Ukoumunne O, Thiem U . Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2021; 83(3):1073-1087. DOI: 10.3233/JAD-210250. View

16.

Song Rong S, Lee B, Kuk A, Yu X, Li S, Li J . Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: a meta-analysis. Br J Ophthalmol. 2019; 103(12):1777-1783. DOI: 10.1136/bjophthalmol-2018-313277. View

17.

Tsai H, Lo R, Liang K, Chen T, Huang H, Wang J . Risk of Subsequent Dementia or Alzheimer Disease Among Patients With Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. Am J Ophthalmol. 2022; 247:161-169. DOI: 10.1016/j.ajo.2022.11.005. View

18.

Choi S, Jahng W, Park S, Jee D . Association of Age-Related Macular Degeneration on Alzheimer or Parkinson Disease: A Retrospective Cohort Study. Am J Ophthalmol. 2019; 210:41-47. DOI: 10.1016/j.ajo.2019.11.001. View

19.

Yoon J, Lim D, Youn J, Han K, Kim B, Jung W . Increased risk of Parkinson's disease amongst patients with age-related macular degeneration and visual disability: A nationwide cohort study. Eur J Neurol. 2023; 30(9):2641-2649. DOI: 10.1111/ene.15896. View

20.

Pengo M, Murueta-Goyena A, Teijeira-Portas S, Acera M, Del Pino R, Saez-Atxukarro O . Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson's Disease. J Parkinsons Dis. 2022; 12(5):1633-1643. DOI: 10.3233/JPD-213143. View